| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 235.89 Million | USD 629.86 Million | 11.53% | 2024 |
FrequentlyAsked Questions
A lung stent, also called an airway or bronchial stent, is a small medical tube placed inside the airways to keep them open and help a person breathe easily. It is placed during a bronchoscopy procedure and is used to treat breathing difficulties caused by cancer, scar tissue, structural airway problems, or other conditions.
The global lung stent market is expected to grow due to rising lung cancer incidence, increasing prevalence of respiratory diseases, growing adoption of minimally invasive bronchoscopic procedures, expanding interventional pulmonology services, and ongoing innovation in stent materials and designs that make treatment safer and more effective.
According to the study, the global lung stent market size was worth around USD 235.89 million in 2024 and is predicted to grow to around USD 629.86 million by 2034.
The compound annual growth rate value of the lung stent market is expected to be around 11.53% from 2025 to 2034.
North America is expected to lead the global lung stent market due to high lung cancer incidence rates, a well-developed interventional pulmonology specialty, advanced bronchoscopy infrastructure, strong reimbursement support, and significant research investment in airway stent technology.
The major players profiled in the global lung stent market include Boston Scientific Corporation, Olympus Corporation, Merit Medical Systems, Cook Medical, Novatech, Micro-Tech Endoscopy, Taewoong Medical, Hood Laboratories, Diagmed Healthcare, and Fuji Systems Corporation.
The report provides a detailed analysis of the lung stent market, including a thorough review of key growth drivers and market restraints, clinical technology trends, advances in stent design and materials, regional market performance, competitive landscape analysis, and a comprehensive forward-looking outlook covering all major product types, indications, end users, and materials across every key geography.
Pricing trends in the lung stent market show moderate increases driven by advanced materials, higher manufacturing costs, and premium pricing for innovative stents, such as biodegradable and drug-eluting designs.
Emerging trends in the lung stent market include 3D-printed patient-specific stents, biodegradable materials, and drug-eluting coatings that reduce complications, along with growing adoption of minimally invasive procedures and advanced bronchoscopy technologies.
Technological advancements in the lung stent market are improving precision, safety, and outcomes through better bronchoscopy systems, innovative stent designs, and minimally invasive techniques, thereby increasing adoption and supporting steady global market growth.
HappyClients